Delivery Order SPE2DB20D2104-SPE2DB22FS10P
Award Date
3/16/22
Potential Completion Date
3/17/22
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, issued by the Defense Logistics Agency (DLA), is for the delivery of Lantus 100 unit/mL vial 10mL to the government. The $1,084.22 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,001.43, is for the delivery of Lantus 100 unit/mL vial, 10 mL, a specialty medication used for the treatment of diabetes. The contract is a firm fixed-price delivery order with an ultimate completion date of April 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,155.77 delivery order contract is for the supply of Lantus 100 unit/ml vial (10 ml), a specialty medication used for the treatment of diabetes. The contract has an ultimate completion date of May 31, 2023 and is a firm fixed-price agreement. This award is part of a larger Indefinite Delivery Contract (IDC) held...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,063.88, is for the delivery of Lantus 100 unit/mL vial, a medication used to treat diabetes. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Lantus 100 unit/mL vial 10mL, a diabetes medication. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $2,351.59 and a performance period through May 1, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,278.10, is a delivery order for the supply of Lantus 100 unit/mL vial 10mL, a diabetes medication. The contract has an ultimate completion date of April 21, 2025 and is a firm fixed-price contract. This award is not associated with a set-aside program and is part of a larger Indefinite...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,709.98 firm-fixed-price contract is for the provision of Lantus 100 Unit/ML Vial 10ML, a prescription medication. The contract has an ultimate completion date of August 9, 2024. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999, and the...
This federal contract award is from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,897.50 firm fixed-price delivery order is for the supply of Lantus 100 unit/mL vial, a prescription insulin medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $1,025.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is for the delivery of Lantus 100 Unit/mL Vial 10mL, a prescription medication, to DLA facilities supporting the Department of Defense worldwide. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus insulin vials. The $2,865.84 fixed-price contract has a completion date of September 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical...